GDPD5: A Protein Implicated in Disease Development (G81544)

Target Name: GDPD5

NCBI ID: G81544

GDPD5

Other Name(s): phosphoinositide phospholipase C GDPD5 | GDE2 | Glycerophosphodiester phosphodiesterase domain-containing protein 5 (isoform 1) | glycerophosphocholine phosphodiesterase GDPD5 | GDPD5_HUMAN | Glycerophosphodiester phosphodiesterase 2 | PP1665 | Glycerophosphodiester phosphodiesterase domain-containing protein 5 | Glycerophosphocholine phosphodiesterase GDPD5 | glycerophosphodiester phosphodiesterase 2 | Phosphoinositide phospholipase C GDPD5 | GDPD5 variant 1 | Glycerophosphodiester phosphodiesterase domain containing 5, transcript variant 1 | glycerophosphodiester phosphodiesterase domain containing 5

GDPD5: A Protein Implicated in Disease Development

GDPD5 (phosphoinositide phospholipase C GDPD5) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key enzyme in the intracellular signaling pathway known as the PI3K/Akt pathway, which is involved in a wide range of physiological processes, including cell signaling, inflammation, and metabolism.

In recent years, researchers have become increasingly interested in GDPD5 as a potential drug target or biomarker. This is because the PI3K/Akt pathway has been implicated in the development and progression of many diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. Additionally , the PI3K/Akt pathway is often disrupted in diseases, such as diabetes and hypertension, and may be a target for therapeutic intervention.

GDPD5 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key enzyme in the intracellular signaling pathway known as the PI3K/Akt pathway, which is involved in a wide range of physiological processes, including cell signaling, inflammation, and metabolism.

One of the key functions of GDPD5 is its role in the PI3K/Akt pathway. This pathway is a well-established signaling pathway that is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. The PI3K/Akt pathway is activated by the phosphorylation of a protein called phosphatidylinositol at its IP3-binding site, and this event is mediated by GDPD5.

GDPD5 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key enzyme in the intracellular signaling pathway known as the PI3K/Akt pathway, which is involved in a wide range of physiological processes, including cell signaling, inflammation, and metabolism.

Another function of GDPD5 is its role in the regulation of cellular processes, including cell signaling and inflammation. GDPD5 has been shown to be involved in the regulation of various cellular signaling pathways, including the T-cell signaling pathway and the chemokine receptor signaling pathway. It has also been shown to play a role in the regulation of inflammation, both in the context of neurodegenerative diseases and in the context of inflammatory diseases.

In addition to its role in the PI3K/Akt pathway, GDPD5 has also been shown to have a number of other functions in the body. For example, it has been shown to play a role in the regulation of cell volume and the maintenance of cellular homeostasis. It has also been shown to play a role in the regulation of protein synthesis and metabolism, as well as in the regulation of cellular processes such as cell adhesion and migration.

Despite its many functions, GDPD5 is still an relatively little-studied protein. There is currently limited research on the biology and chemistry of GDPD5, and there are few potential drug targets or biomarkers that have been identified. However, as research on GDPD5 continues, it is likely that new functions and potential therapeutic applications for this protein will be discovered.

In conclusion, GDPD5 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key enzyme in the intracellular signaling pathway known as the PI3K/Akt pathway, and it has been implicated in the development and progression of many diseases. Additionally, GDPD5 is a potential drug target or biomarker, and further research is needed to fully understand its biology and functions.

Protein Name: Glycerophosphodiester Phosphodiesterase Domain Containing 5

Functions: Glycerophosphodiester phosphodiesterase that promotes neurite formation and drives spinal motor neuron differentiation (By similarity). Mediates the cleavage of glycosylphosphatidylinositol (GPI) anchor of target proteins: removes the GPI-anchor of RECK, leading to release RECK from the plasma membrane (By similarity). May contribute to the osmotic regulation of cellular glycerophosphocholine (By similarity)

The "GDPD5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GDPD5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets